These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2155068)
1. Nitrendipine binding in congestive heart failure due to myocardial infarction. Dixon IM; Lee SL; Dhalla NS Circ Res; 1990 Mar; 66(3):782-8. PubMed ID: 2155068 [TBL] [Abstract][Full Text] [Related]
2. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Dixon IM; Hata T; Dhalla NS Am J Physiol; 1992 May; 262(5 Pt 2):H1387-94. PubMed ID: 1317126 [TBL] [Abstract][Full Text] [Related]
3. Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction. Dixon IM; Hata T; Dhalla NS Am J Physiol; 1992 Mar; 262(3 Pt 1):C664-71. PubMed ID: 1312780 [TBL] [Abstract][Full Text] [Related]
4. Experimental congestive heart failure due to myocardial infarction: sarcolemmal receptors and cation transporters. Dhalla NS; Dixon IM; Rupp H; Barwinsky J Basic Res Cardiol; 1991; 86 Suppl 3():13-23. PubMed ID: 1664205 [TBL] [Abstract][Full Text] [Related]
5. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules. Murphy BJ; Tuana BS Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734 [TBL] [Abstract][Full Text] [Related]
6. Adaptational process of the cardiac Ca2+ channels to pressure overload: biochemical and physiological properties of the dihydropyridine receptors in normal and hypertrophied rat hearts. Mayoux E; Callens F; Swynghedauw B; Charlemagne D J Cardiovasc Pharmacol; 1988 Oct; 12(4):390-6. PubMed ID: 2465438 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone. Seppet EK; Kolar F; Dixon IM; Hata T; Dhalla NS Mol Cell Biochem; 1993 Dec; 129(2):145-59. PubMed ID: 8177237 [TBL] [Abstract][Full Text] [Related]
8. Sarcolemmal Ca2+ transport activities in cardiac hypertrophy caused by pressure overload. Nakanishi H; Makino N; Hata T; Matsui H; Yano K; Yanaga T Am J Physiol; 1989 Aug; 257(2 Pt 2):H349-56. PubMed ID: 2548404 [TBL] [Abstract][Full Text] [Related]
9. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats. Sandmann S; Min JY; Meissner A; Unger T Cardiovasc Res; 1999 Oct; 44(1):67-80. PubMed ID: 10615391 [TBL] [Abstract][Full Text] [Related]
10. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups. Murphy BJ; Washkurak AW; Tuana BS Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349 [TBL] [Abstract][Full Text] [Related]
11. Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy. Lee SL; Ostadalova I; Kolar F; Dhalla NS Mol Cell Biochem; 1992 Feb; 109(2):173-9. PubMed ID: 1320733 [TBL] [Abstract][Full Text] [Related]
12. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium. Rasmussen RP; Minobe W; Bristow MR Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992 [TBL] [Abstract][Full Text] [Related]
13. Increased [3H]nitrendipine binding sites in rat heart during adult maturation and aging. Navaratnam S; Khatter JC Biochem Pharmacol; 1991 Feb; 41(4):593-600. PubMed ID: 1847636 [TBL] [Abstract][Full Text] [Related]
14. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes. Bolger GT; Marcus KA; Daly JW; Skolnick P J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279 [TBL] [Abstract][Full Text] [Related]